GT Biopharma annual debt-to-equity ratio
2017
2018
2021
2022
2023
GT Biopharma Debt-to-Equity Ratio Growth & History (GTBP)
GT Biopharma's debt-to-equity ratio was 0.01 for fiscal 2023.
View full GT Biopharma company overviewGT Biopharma annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | 0.01 | −0.01 | −47.68% |
| 2022 | 2022-12-31 | 0.01 | 0.01 | +948.05% |
| 2021 | 2021-12-31 | 0.00 | — | — |
| 2018 | 2018-12-31 | 0.00 | 0.00 | — |
| 2017 | 2017-12-31 | 0.00 | — | — |
GT Biopharma quarterly debt-to-equity ratio
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q1.24
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2024 | 2024-03-31 | 0.01 | −0.01 | −53.05% |
| Q3 2023 | 2023-09-30 | 0.01 | 0.01 | — |
| Q2 2023 | 2023-06-30 | 0.01 | 0.01 | — |
| Q1 2023 | 2023-03-31 | 0.01 | 0.01 | — |
| Q4 2022 | 2022-12-31 | 0.01 | 0.01 | — |
| Q3 2022 | 2022-09-30 | 0.00 | 0.00 | — |
| Q2 2022 | 2022-06-30 | 0.00 | 0.00 | — |
| Q1 2022 | 2022-03-31 | 0.00 | 0.00 | — |
| Q4 2021 | 2021-12-31 | 0.00 | — | — |
| Q3 2021 | 2021-09-30 | 0.00 | — | — |
| Q2 2021 | 2021-06-30 | 0.00 | — | — |
| Q1 2021 | 2021-03-31 | 0.00 | — | — |
| Q2 2019 | 2019-06-30 | 0.02 | 0.02 | — |
| Q1 2019 | 2019-03-31 | 0.02 | 0.02 | — |
| Q4 2018 | 2018-12-31 | 0.00 | 0.00 | — |
| Q3 2018 | 2018-09-30 | 0.00 | 0.00 | — |
| Q2 2018 | 2018-06-30 | 0.00 | — | — |
| Q1 2018 | 2018-03-31 | 0.00 | — | — |
| Q4 2017 | 2017-12-31 | 0.00 | — | — |
| Q3 2017 | 2017-09-30 | 0.00 | — | — |
GT Biopharma debt-to-equity ratio trends
Over the last five fiscal years, GT Biopharma's debt-to-equity ratio increased from 0.00 to 0.01, a change of 0.01. The latest reported quarter, Q1 2024, shows 0.01.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GT Biopharma source filings ↗